Biotricity, Inc.

BTCY · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income-$8,421-$14,094-$18,658-$29,130
Dep. & Amort.$6$2,173$6$2
Deferred Tax$0$0$484$684
Stock-Based Comp.$1,462$1,026$648$914
Change in WC$962$3,683$2,309-$118
Other Non-Cash$3,611$519$1,664$12,485
Operating Cash Flow-$2,380-$6,694-$13,548-$15,163
Investing Activities
PP&E Inv.$0$0$0-$30
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$30
Financing Activities
Debt Repay.$101$3,815$3,831$10,596
Stock Issued$125$119$13$15,768
Stock Repurch.$0$0-$896-$230
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$13$872
Financing Cash Flow$1,929$6,742$2,002$25,168
Forex Effect$30$168$50-$110
Net Chg. in Cash-$421$216-$11,496$9,865
Supplemental Information
Beg. Cash$786$570$12,067$2,202
End Cash$365$786$570$12,067
Free Cash Flow-$2,380-$6,694-$13,548-$15,193